Spread and Scale of a Polypharmacy App

NAUnknownINTERVENTIONAL
Enrollment

1,000

Participants

Timeline

Start Date

August 1, 2021

Primary Completion Date

July 31, 2022

Study Completion Date

October 31, 2022

Conditions
PolypharmacyDeprescribingAdverse Drug Event
Interventions
OTHER

MedReviewRx

During the intervention phase, MedReviewRx will be made available to nursing homes with the understanding that it will be used to facilitate medication reviews and prescription check-ups. MedReviewRx provides clinicians with access to individualized and prioritized deprescribing information from MedSafer which: a) identifies potentially inappropriate medications (PIMs), b) explains why the medication is potentially inappropriate and c) provides instructions on how to safely stop/taper the medication.

Trial Locations (5)

E3A 1A3

York Care Centre, Fredericton

E1E 3R8

Faubourg du Mascaret, Moncton

E1E 4N3

Spencer Nursing Home, Moncton

E2E 0M4

Shannex Embassy Hall, Quispamsis

E2J 3S3

Loch Lomond Villa, Saint John

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

McGill University Health Centre/Research Institute of the McGill University Health Centre

OTHER

collaborator

Horizon Health Network

OTHER

collaborator

Missing Link Technologies

UNKNOWN

collaborator

New Brunswick Community College

UNKNOWN

lead

Centre for Innovation and Research in Aging, Canada

OTHER

NCT04762303 - Spread and Scale of a Polypharmacy App | Biotech Hunter | Biotech Hunter